Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a ...
Get the latest on Scholar Rock's regulatory strategy, financial outlook, and apitegromab launch plans for SMA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback